13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001795097
Total reported value
$544.2M
$544.2M
57 檔
49.9%
As reported in its official Q4 2025 Form 13F filing, Privium Fund Management B.V.'s tracked investment portfolio stood at $544.2M with 57 total positions.
Privium Fund Management B.V. executed strategic sector rebalancing during Q4 2025, establishing 5 new positions while fully exiting 8 holdings and trimming 11 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TSLA | Tesla Inc | Stock-Consumer Disc | 18.92% | +0.44% | -6.35% | |
| 2 | SHOP | Shopify Inc - Class A | Stock-Tech | 12.15% | -2.29% | -1.20% | |
| 3 | SPOT | Spotify Technology S.A. | Stock-Comm Services | 7.27% | -2.12% | -28.42% | |
| 4 | PLTR | Palantir Technologies Inc-a | Stock-Tech | 6.55% | -1.80% | — | |
| 5 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 5.14% | +0.71% | -18.79% | |
| 6 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 4.87% | -1.28% | -15.98% | |
| 7 | IONS | Ionis Pharmaceuticals Inc | Stock-Healthcare | 3.51% | +0.13% | -3.24% | |
| 8 | COIN | Coinbase Global Inc -class A | Stock-Financials | 3.29% | -2.87% | EXIT | |
| 9 | LMND | Lemonade Inc | Stock-Financials | 3.25% | -0.10% | +71.21% | |
| 10 | SE | Sea Ltd-adr | Stock-Comm Services | 3.24% | -2.38% | EXIT | |
| 11 | NVDA | Nvidia CORP | Stock-Tech | 2.78% | +0.04% | — | |
| 12 | BIIB | Biogen Inc | Stock-Healthcare | 2.38% | +0.25% | +41.51% | |
| 13 | AMD | Advanced Micro Devices | Stock-Tech | 2.37% | +3.99% | — | |
| 14 | ✓ | Proqr Therapeutics N.v. | Stock-Other | 1.99% | +0.05% | +7.19% | |
| 15 | IREN | IREN Limited | Stock-Other | 1.95% | +0.58% | +115.38% | |
| 16 | ASTS | Ast Spacemobile Inc | Stock-Tech | 1.94% | -0.13% | +31.82% | |
| 17 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 1.91% | -0.27% | +7.86% | |
| 18 | QURE | uniQure N.V. | Stock-Other | 1.83% | +1.12% | +7.84% | |
| 19 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | 1.64% | +0.35% | — | |
| 20 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 1.51% | +0.49% | +23.36% | |
| 21 | VRDN | Viridian Therapeutics Inc | Stock-Other | 0.99% | -0.12% | — | |
| 22 | URGN | UroGen Pharma Ltd. | Stock-Other | 0.93% | +0.53% | +9.15% | |
| 23 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 0.78% | -0.20% | +12.71% | |
| 24 | MRK | Merck & Co. Inc. | Stock-Healthcare | 0.71% | — | -43.17% | |
| 25 | WVE | Wave Life Sciences Ltd. | Stock-Other | 0.60% | -0.10% | +13.54% | |
| 26 | ✓ | Engene Holdings Inc | Stock-Other | 0.59% | -0.50% | EXIT | |
| 27 | BNTX | Biontech Se-adr | Stock-Other | 0.58% | +0.01% | +75.26% | |
| 28 | KRYS | Krystal Biotech Inc | Stock-Healthcare | 0.55% | +0.16% | — | |
| 29 | ABEV | Ambev Sa-adr | Stock-Consumer Staples | 0.48% | -0.12% | +18.51% | |
| 30 | ZLAB | Zai Lab Ltd-adr | Stock-Other | 0.43% | -0.09% | — | |
| 31 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 0.41% | +0.03% | +7.18% | |
| 32 | BEAM | Beam Therapeutics Inc | Stock-Other | 0.36% | +0.12% | +17.21% | |
| 33 | LXEO | Lexeo Therapeutics Inc | Stock-Other | 0.35% | -0.11% | +0.10% | |
| 34 | STOK | Stoke Therapeutics Inc | Stock-Other | 0.32% | -0.34% | EXIT | |
| 35 | MGTX | MeiraGTx Holdings plc | Stock-Other | 0.29% | +0.11% | +22.70% | |
| 36 | FDMT | 4d Molecular Therapeutics In | Stock-Other | 0.29% | -0.11% | +6.35% | |
| 37 | SLB | Slb LTD | Stock-Energy | 0.27% | -0.20% | EXIT | |
| 38 | MRNA | Moderna Inc | Stock-Healthcare | 0.27% | +0.07% | +5.52% | |
| 39 | HIMS | Hims & Hers Health Inc | Stock-Healthcare | 0.24% | +0.34% | — | |
| 40 | RNAC | Cartesian Therapeutics Inc | Stock-Other | 0.23% | +0.06% | — | |
| 41 | VZLA | Vizsla Silver CORP | Stock-Other | 0.21% | — | — | |
| 42 | PFE | Pfizer Inc | Stock-Healthcare | 0.17% | -0.31% | EXIT | |
| 43 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 0.17% | +0.24% | — | |
| 44 | TSHA | Taysha Gene Therapies Inc | Stock-Other | 0.17% | +0.08% | +22.24% | |
| 45 | NOV | Nov Inc | Stock-Energy | 0.15% | -0.02% | -16.83% | |
| 46 | SEA1EUR | Seabridge Gold Inc | Stock-Other | 0.13% | -0.15% | EXIT | |
| 47 | AUTL | Autolus Therapeutics PLC | Stock-Other | 0.12% | +0.01% | +5.64% | |
| 48 | RCKT | Rocket Pharmaceuticals Inc | Stock-Other | 0.11% | -0.03% | -60.68% | |
| 49 | RIG | Transocean Ltd. | Stock-Energy | 0.11% | -0.02% | +36.87% | |
| 50 | SD | Sandridge Energy Inc | Stock-Other | 0.10% | -0.03% | -23.02% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ARWR | Arrowhead Pharmaceuticals In | +1.9% | -15.98% | Trim |
| 2 | LMND | Lemonade Inc | +1.9% | +71.21% | Add |
| 3 | BIIB | Biogen Inc | +1.1% | +41.51% | Add |
| 4 | SHOP | Shopify Inc - Class A | +1.1% | -1.20% | Trim |
| 5 | ASTS | Ast Spacemobile Inc | +1% | +31.82% | Add |
| 6 | IREN | IREN Limited | +0.9% | +115.38% | Add |
| 7 | AXSM | Axsome Therapeutics Inc | +0.8% | +7.86% | Add |
| 8 | AMD | Advanced Micro Devices | +0.6% | — | Unchanged |
| 9 | ARQT | Arcutis Biotherapeutics Inc | +0.6% | — | Unchanged |
| 10 | IONS | Ionis Pharmaceuticals Inc | +0.6% | -3.24% | Trim |
| 11 | WVE | Wave Life Sciences Ltd. | +0.4% | +13.54% | Add |
| 12 | BNTX | Biontech Se-adr | +0.2% | +75.26% | Add |
| 13 | URGN | UroGen Pharma Ltd. | +0.2% | +9.15% | Add |
| 14 | VRTX | Vertex Pharmaceuticals Inc | +0.2% | +12.71% | Add |
| 15 | KRYS | Krystal Biotech Inc | +0.2% | — | Unchanged |
| 16 | SLB | Slb LTD | +0.2% | +97.01% | Add |
| 17 | LXEO | Lexeo Therapeutics Inc | +0.1% | +0.10% | Add |
| 18 | ABEV | Ambev Sa-adr | +0.1% | +18.51% | Add |
| 19 | BEAM | Beam Therapeutics Inc | +0.1% | +17.21% | Add |
| 20 | TSHA | Taysha Gene Therapies Inc | +0.1% | +22.24% | Add |
| 21 | RIG | Transocean Ltd. | +0.1% | +36.87% | Add |
| 22 | MRNA | Moderna Inc | +0.1% | +5.52% | Add |
| 23 | PLTR | Palantir Technologies Inc-a | 0% | — | Unchanged |
| 24 | RARE | Ultragenyx Pharmaceutical In | -0.1% | +23.36% | Add |
| 25 | CRSP | CRISPR Therapeutics AG | -0.1% | +7.18% | Add |
| 26 | URNM | Sprott Uranium Miners ETF | -0.1% | -52.77% | Trim |
| 27 | SEA1EUR | Seabridge Gold Inc | -0.1% | -50.99% | Trim |
| 28 | RCKT | Rocket Pharmaceuticals Inc | -0.1% | -60.68% | Trim |
| 29 | HIMS | Hims & Hers Health Inc | -0.2% | — | Unchanged |
| 30 | MRK | Merck & Co. Inc. | -0.3% | -43.17% | Trim |
| 31 | ZLAB | Zai Lab Ltd-adr | -0.4% | — | Unchanged |
| 32 | TSLA | Tesla Inc | -0.6% | -6.35% | Trim |
| 33 | AMZN | Amazon.com Inc | -0.7% | -18.79% | Trim |
| 34 | COIN | Coinbase Global Inc -class A | -1.5% | — | Unchanged |
| 35 | SE | Sea Ltd-adr | -1.9% | -13.75% | Trim |
| 36 | QURE | uniQure N.V. | -2.2% | +7.84% | Add |
| 37 | SPOT | Spotify Technology S.A. | -4.7% | -28.42% | Trim |
| 38 | VRDN | Viridian Therapeutics Inc | — | NEW | New buy |
| 39 | ✓ | Engene Holdings Inc | — | NEW | New buy |
| 40 | ABVX | Abivax Sa-adr | — | EXIT | Sold out |
| 41 | RNAGBP | Avidity Biosciences Inc | — | EXIT | Sold out |
| 42 | ROIV | Roivant Sciences Ltd. | — | EXIT | Sold out |
| 43 | STOK | Stoke Therapeutics Inc | — | NEW | New buy |
| 44 | ACAD | Acadia Pharmaceuticals Inc | — | EXIT | Sold out |
| 45 | RNAC | Cartesian Therapeutics Inc | — | NEW | New buy |
| 46 | ALXO | Alx Oncology Holdings Inc | — | EXIT | Sold out |
| 47 | SRPT | Sarepta Therapeutics Inc | — | NEW | New buy |
| 48 | PAAS | Pan American Silver CORP | — | EXIT | Sold out |
| 49 | RXRX | Recursion Pharmaceuticals-a | — | EXIT | Sold out |
| 50 | SBSW | Sibanye-stillwater Ltd-adr | — | EXIT | Sold out |
According to official SEC Form 13F filings, Privium Fund Management B.V. reported a total U.S. public equity portfolio value of $544.2M across 57 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including TSLA, SHOP, SPOT) accounted for 49.9% of total reported equity market value during Q4 2025.
Top New Position Initiated
VRDN
市值: $5.4M
Top Position Liquidated / Trimmed
ABVX
前期市值: $2.6M
During Q4 2025, Privium Fund Management B.V.'s top holdings by market value included TSLA (18.9%)、SHOP (12.2%)、SPOT (7.3%). The largest single position, TSLA, represented 18.9% of total portfolio value.
In Q4 2025, Privium Fund Management B.V. made 43 total portfolio adjustments, initiating 5 new buys, adding to 19 positions, trimming 11 holdings, and fully liquidating 8 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.